Spain vs Switzerland: Access to anti-retroviral drugs, male
Spain
91.0%
in 2022
Switzerland
90.0%
in 2023
Spain rank
12th
Switzerland rank
13th
Access to anti-retroviral drugs, male over time
- Spain
- Switzerland
How they compare
Spain currently reports 91.0% against 90.0% in Switzerland, a difference of 1.0%.
The two have swapped places 1 time across 23 shared years of data; in 2000 it was Switzerland ahead.
Spain ranks 12th and Switzerland ranks 13th of 141 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Spain | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.7% | 50.0% | 8.3% | Switzerland |
| 2010s | 73.4% | 79.2% | 5.8% | Switzerland |
| 2020s | 88.7% | 90.3% | 1.7% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Spain or Switzerland?
- Spain, at 91.0% against 90.0% in Switzerland as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Spain and Switzerland?
- 1.0%, with Spain ahead.
- How many years of comparable data are there for Spain and Switzerland?
- 23 years are reported by both, from 2000 to 2022.
- How do Spain and Switzerland rank globally for access to anti-retroviral drugs, male?
- Spain ranks 12th and Switzerland ranks 13th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.